news aktuell GmbH

TXOne Networks: Disruptions from Ransomware and Cyberattacks on Supply Chains and Critical Infrastructure Sharpen Focus on OT Security for 2023, TXOne Networks and Frost & Sullivan Analysis Reveals

Del
TXOne Networks, global leader of OT-native security solutions for ICS, delivers an in-depth report on the contemporary threat landscape.
Annual Report "Insights Into ICS/OT Cybersecurity 2022" by TXOne Networks and Frost & Sullivan
Annual Report "Insights Into ICS/OT Cybersecurity 2022" by TXOne Networks and Frost & Sullivan

EINDHOVEN (Netherlands) and TAIPEI, Taiwan, Feb 28th, 2023 - TXOne Networks, a global leader in the industrial Internet of Things (IIoT) security, published its 2022 annual report detailing growth today in disruptive ransomware extortion and attacks on supply chains and critical infrastructure assets. Insights Into ICS/OT Cybersecurity 2022, which is publicly available for free download, delves into the driving forces in industrial control system (ICS) security, such as convergence of operational and information technology (OT and IT), intensified regulatory focus, rise in trade protectionism globally and heightened awareness of potential losses from attacks on the OT environment.

Produced in collaboration with Frost & Sullivan, Insights Into ICS/OT Cybersecurity 2022 is based on a survey of 300 C-level officers, directors, and other managers with varied organizations in advanced manufacturing countries around the world. The report provides an in-depth analysis of the contemporary OT threat landscape and delivers actionable information that organizations can leverage in developing practical, operations-friendly approaches to OT cyber defense.

When it comes to cybersecurity, technology leaps forward at an accelerated and unpredictable pace, which means that threats posed by bad actors only stay on the horizon briefly before becoming a dire reality. For this reason, TXOne Networks has taken a close multilayered look at the recent history of OT security in 2022 and reported their findings in Insights Into ICS/OT Cybersecurity 2022. Researchers investigated the way the threat landscape changed last year, given 2022’s emergence of Ransomware as a Service (RaaS) offerings. Ecosystem-complete services such as Black Basta, Pandora, and LockBit 3.0 employed ruthless multiple-extortion strategies that are likely to persist across critical manufacturing, energy, agriculture, healthcare, and public health industries with an especially significant impact on the automotive sector, further precipitating the need for OT-specific taskforces and solutions. The report also includes regulations set forth by governments to bolster cybersecurity defenses against looming global threats as geopolitical tensions continue to rise, turning cybersecurity into the law of the land. Additionally, TXOne explains the market forces that are also driving verticals across the board into investing in OT-specific security and how organizations are expanding their budgets for OT and getting ready for widespread adoption. Read here for a comprehensive breakdown on all these factors and the way they holistically form the big picture of OT cybersecurity in recent history and in the near future.

“In ICS/OT, there are many constraints imposed by design. Addressing security issues under such circumstances requires a unique set of solutions and methods, as opposed to repurposed approaches from IT,” said Terence Liu, chief executive officer (CEO) of TXOne Networks. “OT-native cyber defenses for ICS/OT are entering the mainstream. As ICS/OT evolves over time, new technology adoptions like IIoT, hybrid cloud and 5G networks will continue to ramp up, and visionary solution providers are preparing for that future.”

Download TXOne Networks’ Insights Into ICS/OT Cybersecurity 2022.

Follow TXOne Networks on Blog, Twitter, and LinkedIn.

About TXOne Networks

TXOne Networks offers cybersecurity solutions that ensure the reliability and safety of industrial control systems and operational technology environments through the OT zero trust methodology. TXOne Networks works together with both leading manufacturers and critical infrastructure operators to develop practical, operations-friendly approaches to cyber defense. TXOne Networks offers both network-based and endpoint-based products to secure the OT network and mission-critical devices in a real-time, defense-in-depth manner. www.txone.com


Contacts:

Lynette Lee
lynette_lee@txone.com

De Anne O’Connell
deanne_oconnell@txone.com

Minu Seshasayee
Interprose for TXOne Networks
minu_seshasayee@interprosepr.com

+1 425.283.7426

Bilder

Annual Report "Insights Into ICS/OT Cybersecurity 2022" by TXOne Networks and Frost & Sullivan
Annual Report "Insights Into ICS/OT Cybersecurity 2022" by TXOne Networks and Frost & Sullivan
Last ned bilde
Dr. Terence Liu, CEO TXOne Networks
Dr. Terence Liu, CEO TXOne Networks
Last ned bilde

Om news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Følg pressemeldinger fra news aktuell GmbH

Registrer deg med din e-postadresse under for å få de nyeste sakene fra news aktuell GmbH på e-post fortløpende. Du kan melde deg av når som helst.

Siste pressemeldinger fra news aktuell GmbH

iTAC Software AG: Closed Loop: Simulating, planning and managing the digital factory24.5.2023 14:48:14 CEST | Press release

The factory of the future is digital and relies on integrated, rather than isolated, solutions. The software companies DUALIS GmbH IT Solution (www.dualis-it.de) and iTAC Software AG (www.itacsoftware.com) developed a holistic digitalization approach for greater efficiency, flexibility and quality in manufacturing. In the closed loop model, simulation, APS and MES/MOM are closely interlinked and interact with each other. This means, for example, that manufacturing processes can be optimized end-to-end. At the same time, costs and risks can be minimized.

LONGi publishes its annual report for 2022 and 2023 Q124.5.2023 13:06:07 CEST | Press release

Xi'an, China | Frankfurt, Germany: May 24, 2023 - LONGi Green Energy Technology, a global leading renewable energy company, released its annual report for 2022 and 2023 Q1. According to the financial report, the company achieved a revenue of 128.998 billion yuan in 2022 (USD 19.27 bn), a year-on-year increase of 60.03%. This is the first time that LONGi’s yearly revenue stands above the 100 bn yuan (USD 14.93 bn) level.

Grünenthal’s resiniferatoxin receives Breakthrough Therapy Designation from U.S. FDA for pain associated with osteoarthritis of the knee22.5.2023 10:49:28 CEST | Press release

Knee osteoarthritis is a progressive condition affecting over 360 million people worldwide and may have severe symptoms, including pain. Grünenthal is running a global Phase III programme to investigate the efficacy and safety of intra-articular injections of resiniferatoxin, a non-opioid therapy, in adults with pain associated with knee osteoarthritis. The U.S. Food and Drug Administration’s Breakthrough Therapy Designation process aims to expedite the development of investigational medicines intended to treat severe conditions and where preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapy on clinically significant endpoints.

I vårt presserom finner du alle våre siste pressemeldinger, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom